She was granted the Knight Grade as an acknowledgment of the Foundation’s president in the fields of science and health, especially regarding the actions undertaken by the institution in the fight against the COVID-19 pandemic
Fiocruz International News - September 2021
The document signed establishes the technical cooperation terms between Fiocruz and the Special Program for Research and Training in Tropical Diseases of the World Health Organization (TDR/WHO)
The United Kingdom government wants to expand its scientific partnership with Fiocruz, especially in fields such as genomic sequencing, declared the minister counselor of the British Embassy in Brazil, Melanie Hopkins
A research coordinated by Oxford University in the United Kingdom points out that the Pfizer and AstraZeneca vaccines, this one produced in Brazil by Fiocruz, also guarantee protection against infection with the Delta variant of COVID-19
Health at Triple Border is subject of meeting organized in Amazonia
The event organized by Fiocruz Amazônia aims at strengthening post-graduate programs through partnerships between the universities and research institutions of the Alto Solimões region, an area at Brazil's, Colombia's and Peru's frontier
Seminar debates current situation and 2030 Agenda perspectives
The event from Fiocruz Global Health Center presented an updated assessment of the Sustainable Development Goals (SDGs) at global, regional and national levels, pointing out criticisms and alternatives for the Agenda implementation
Fiocruz will produce 60 million antigen tests for Brazilian public health system
The initiative will allow faster diagnosis of the COVID-19 infection and is part of the expansion of the testing strategy. Tests will be provided according to the demand of the Ministry of Health. Foundation will be responsible for training teams
COVID-19 vaccine: Fiocruz delivers 80 million doses and begins its 100% national production
A milestone of the foundation is related to national sovereignty. The manufacturing of the first pre-validation batch of the COVID-19 vaccine using the Active Pharmaceutical Ingredient (API) produced at Bio-Manguinhos has begun
In a commentary at Lancet Americas, researchers from Fiocruz, UFRJ, USP and UFG defend the "Ubuntu Practice" in the control of the pandemic
"Triatominae: the biology of Chagas disease vectors" was organized by IRR researchers and has the contribution of 40 authors from different countries
In the International Year of Health Professionals, this workforce is exhausted, with old problems, such as gender inequality, aggravated